In this paper, we used an osteocyte cell line IDG-SW3 that differentiates from an early to a mature osteocyte phenotype in culture with progressive mineralization, and unlike other osteocyte lines, expresses fibroblast growth factor 23 (FGF23), which is markedly elevated in CKD.19 This evidence concerns the gene FGF23 and chronic kidney disease.